Literature DB >> 22689445

Novel targets for sepsis-induced kidney injury: the glomerular arterioles and the sympathetic nervous system.

Clive N May1, Paolo Calzavacca, Ken Ishikawa, Christoph Langenberg, Li Wan, Rohit Ramchandra, Rinaldo Bellomo.   

Abstract

Sepsis and septic shock are the most common causes of acute kidney injury (AKI) in the intensive care unit, and mortality remains high despite improvements in our ability to support vital organs. The lack of development of effective treatments is partly because there has been little advance in our understanding of the pathophysiology of septic AKI, owing to the difficulty in conducting experiments on critically ill patients and use of inappropriate experimental models. Recently, however, a number of new concepts have emerged that challenge existing dogma and give insights into the causes of AKI. Traditionally, renal ischaemia has been proposed as the main cause of AKI, but it is becoming apparent that in sepsis with a hyperdynamic circulation, the most common situation in septic patients, there is an increase or at least no decrease in renal blood flow. In this review, the possible role of changes in pre- and postglomerular resistance in setting the increased level of renal blood flow in the presence of a decreased glomerular filtration rate is discussed. New evidence also indicates that the increased sympathetic nerve activity that occurs in sepsis may contribute to the induction of organ failure. Experimental studies indicate that inhibition of central sympathetic outflow with α(2)-adrenoceptor agonists or treatment with β(1)-adrenoceptor antagonists might reduce mortality in experimental endotoxaemia and sepsis. The possibility that these beneficial actions are partly dependent on a reduction in the excessive cytokine release caused by marked and prolonged sympathetic activation is discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22689445     DOI: 10.1113/expphysiol.2011.061804

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  7 in total

1.  Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Authors:  Martin Matejovic; Can Ince; Lakhmir S Chawla; Roland Blantz; Bruce A Molitoris; Mitchell H Rosner; Mark D Okusa; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-28       Impact factor: 10.121

Review 2.  Renal Hemodynamics, Function, and Oxygenation in Critically Ill Patients and after Major Surgery.

Authors:  Sven-Erik Ricksten; Gudrun Bragadottir; Lukas Lannemyr; Bengt Redfors; Jenny Skytte
Journal:  Kidney360       Date:  2021-03-03

Review 3.  AKI and the Neuroimmune Axis.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Semin Nephrol       Date:  2019-01       Impact factor: 5.299

4.  Meclofenamate elicits a nephropreventing effect in a rat model of ischemic acute kidney injury by suppressing indoxyl sulfate production and restoring renal organic anion transporters.

Authors:  Chika Saigo; Yui Nomura; Yuko Yamamoto; Masataka Sagata; Rika Matsunaga; Hirofumi Jono; Kazuhiko Nishi; Hideyuki Saito
Journal:  Drug Des Devel Ther       Date:  2014-08-13       Impact factor: 4.162

5.  Renal effects of treatment with a TLR4 inhibitor in conscious septic sheep.

Authors:  Johan Fenhammar; Mats Rundgren; Kjell Hultenby; Jakob Forestier; Micael Taavo; Ellinor Kenne; Eddie Weitzberg; Stefan Eriksson; Volkan Ozenci; Annika Wernerson; Robert Frithiof
Journal:  Crit Care       Date:  2014-09-03       Impact factor: 9.097

6.  Protocol for a prospective observational study on the association of variables obtained by contrast-enhanced ultrasonography and sepsis-associated acute kidney injury.

Authors:  Ning Liu; Zhongheng Zhang; Yucai Hong; Bing Li; Huabo Cai; Hui Zhao; Junru Dai; Lian Liu; Xin Qian; Qicheng Jin
Journal:  BMJ Open       Date:  2019-07-29       Impact factor: 2.692

7.  Injurious mechanical ventilation causes kidney apoptosis and dysfunction during sepsis but not after intra-tracheal acid instillation: an experimental study.

Authors:  Jan Willem Kuiper; A B Johan Groeneveld; Jack J Haitsma; Lonneke Smeding; Mark P V Begieneman; Serge Jothy; Rosanna Vaschetto; Frans B Plötz
Journal:  BMC Nephrol       Date:  2014-07-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.